Read + Share
Amedeo Smart
Independent Medical Education
Herbst RS, Giaccone G, de Marinis F, Reinmuth N, et al. Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC. N Engl J Med 2020;383:1328-1339.PMID: 32997907
Email
LinkedIn
Facebook
Twitter
Privacy Policy